NimBio

NimBioNimBio
NimBio

NimBio

NimBio develops non-invasive diagnostic tools for early disease detection using advanced biosensing.

Website
DR 72019Active5San Francisco, United States
Rate
Advertise here

About

NimBio offers a proactive care solution for Inflammatory Bowel Disease (IBD) patients through its Inflammometer™ platform, which uses passive biosensing for real-time inflammation monitoring and early flare detection. This platform aims to provide effortless, remote, and personalized care for patients, while enhancing care delivery for hospitals and physicians, optimizing treatment for pharma, and reducing hospitalizations for payers. NimBio's solution focuses on identifying flare causes and offering therapeutic recommendations to prevent complications and optimize IBD management.
Frequently asked

What does NimBio do?

NimBio offers a proactive care solution for Inflammatory Bowel Disease (IBD) patients through its Inflammometer™ platform, which uses passive biosensing for real-time inflammation monitoring and early flare detection. This platform aims to provide effortless, remote, and personalized care for patients, while enhancing care delivery for hospitals and physicians, optimizing treatment for pharma, and reducing hospitalizations for payers. NimBio's solution focuses on identifying flare causes and off…

What is NimBio's revenue?

StartupHub estimates NimBio's annual revenue at $857K (range $500K to $1.2M, 65% confidence), based on comparable companies in the sector.

Where is NimBio headquartered?

NimBio is headquartered in San Francisco, United States.

When was NimBio founded?

NimBio was founded in 2019.

What industry does NimBio operate in?

NimBio operates in Healthcare, Non-invasive, Wearable, HealthTech, MedTech, Biotech.

How many employees does NimBio have?

NimBio has approximately 5 people on record.

HEADCOUNT
5
DOMAIN RATING
7
Comments

No comments yet. Be the first to share your take.